Practice and principles of pharmacodynamic determination of HISS-dependent and HISS-independent insulin action: Methods to quantitate mechanisms of insulin resistance

Medicinal Research Reviews

Volumn 23, Issue 1, 2003, Pages 1-14

  Lautt, W Wayne ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Diabetes; HISS; Insulin resistance; Parasympathetic; Postprandial

Indexed keywords

ACETYLCHOLINE; GLUCOSE; INDOMETACIN; INSULIN; MUSCARINIC RECEPTOR; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; PENTOBARBITAL;

AGING; ARTICLE; CAT; CHRONIC LIVER DISEASE; DOG; FETAL ALCOHOL SYNDROME; HORMONAL REGULATION; HORMONE ACTION; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHARMACODYNAMICS; RAT; SKELETAL MUSCLE; SUGAR INTAKE;

ANIMALS; CATS; DOGS; INSULIN; INSULIN RESISTANCE; LIVER; RATS;

EID: 0037214889     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.10022     Document Type: Article

References (47)

1. Lautt WW. The HISS story overview: A novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes. Can J Physiol Pharmacol 1999;77(8):553-562.
2. Lautt WW, Macedo MP, Sadri P, Takayama S, Ramos FD, Legare DJ. Hepatic parasympathetic nerve-dependent control of peripheral insulin sensitivity is determined by feeding and fasting: Dynamic control of HISS-dependent insulin action. Am J Physiol Gastrointest Liver Physiol 2001;281:G29-G36.
3. Latour MG, Lautt WW. The hepatic vagus nerve in the control of insulin sensitivity. Auton Neurosci 2002;95:125-130.
4. Xie H, Tsybenko VA, Johnson MV, Lautt WW. Insulin resistance of glucose response produced by hepatic denervations. Can J Physiol Pharmacol 1993;71:175-178.
5. Xie H, Lautt WW. Insulin resistance produced by hepatic denervation or muscarinic cholinergic blockade. Proc West Pharmacol Soc 1994;37:39-40.
6. Xie H, Lautt WW. Insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration. Am J Physiol 1996;271:E587-E592.
7. Lautt WW, Wang X, Sadri P, Legare DJ, Macedo MP. Rapid insulin sensitivity test (RIST). Can J Physiol Pharmacol 1998;76:1080-1086.
8. Xie H, Zhu L, Zhang YL, Legare DJ, Lautt WW. Insulin sensitivity tested with a modified euglycemic technique in cats and rats. J Pharmacol Toxicol Meth 1996;35:77-82.
9. Latour MG, Lautt WW. Insulin sensitivity regulated by feeding in the conscious unrestrained rat. Can J Physiol Pharmacol 2002;80:8-12.
10. Takayama S, Legare DJ, Lautt WW. Dynamic control of the release of a hepatic insulin sensitizing substance. Proc West Pharmacol Soc 1999;42:63-64.
11. Xie H, Lautt WW. Induction of insulin resistance by cholinergic blockade with atropine in the cat. J Auton Pharmacol 1995;15:361-369.
12. Xie H, Lautt WW. Insulin resistance of skeletal muscle produced by hepatic parasympathetic interruption. Am J Physiol 1996;270:E858-E863.
13. Takayama S, Legare DJ, Lautt WW. Dose-related atropine-induced insulin resistance: Comparing intraportal versus intravenous administration. Proc West Pharmacol Soc 2000;43:33-34.
14. Sadri P, Lautt WW. Blockade of hepatic nitric oxide synthase causes insulin resistance. Am J Physiol 1999;277:G101-G108.
15. Sadri P, Lautt WW. Insulin resistance caused by hepatic COX inhibition. (Abstract) Diabetes 2000a;49(Suppl 1):A245.
16. Sadri P, Lautt WW. Glucose disposal by insulin, but not IGF-1, is dependent on the hepatic parasympathetic nerves. Can J Physiol Pharmacol 2000b;78:807-812.
17. Lautt WW. State of the Art 1997: Hepatic parasympathetic nerves and glucose metabolism. In: Haussinger D, Jungermann K, editors. Liver and Nervous System. Falk Symposium No. 103. UK: Kluwer Academic Publishers; 1998. p 1-14.
18. Lautt WW, Xie H. Intraportal acetylcholine reverses insulin resistance caused by chronic bile duct ligation. Proc West Pharmacol Soc 1998;41:35-36.
19. Minuk GY, Meyers AFA, Legare DJ, Sadri P, Lautt WW. Fetal exposure to alcohol results in adult insulin resistance in the rat. Proc West Pharmacol Soc 1998;41:39-40.
20. Reid MAG, Latour MG, Legare DJ, Rong N, Lautt WW. Comparison of the rapid insulin sensitivity test (RIST), the insulin tolerance test (ITT), and the hyperinsulinemic euglycemic clamp (HIEC) to measure insulin action in rats. Can J Physiol Pharmacol 2002;80: (in press).
21. Macedo MP, Legare DJ, Lautt WW. Insulin sensitivity is reduced by fasting and elevated by feeding (abstract). N-S Arch Pharmacol 1998;358(1):Suppl 2.R558.
22. Guarino MP, Correia NC, Raposo J, Macedo MP. Is acetylcholine/nitric oxide/cGMP the pathway for hepatic insulin sensitizing substance (HISS) release? Proc West Pharmacol Soc 2002; (in press).
23. Guarino MP, Afonso R, Falmundo N, Raposo J, Macedo MP. Glutathione is critical for hepatic insulin sensitizing substance (HISS) release. Proc West Pharmacol Soc 2002; (in press).
24. Guarino MP, Correia NC, Raposo J, Macedo MP. Nitric oxide synthase inhibition decreases output of hepatic insulin sensitizing substance (HISS), which is reversed by SIN-1 but not by nitroprusside. Proc West Pharmacol Soc 2001;44:25-26.
25. Ribeiro RT, Duarte-Ramos F, Macedo MP. Effect of the hepatic insulin sensitizing substance in the spontaneously hypertensive rat. Proc West Pharmacol Soc 2001;44:27-28.
26. Ribeiro RT, Duarte-Ramos F, Macedo MP. The action of hepatic insulin sensitizing substance is decreased in rats on a high-sucrose diet. Proc West Pharmacol Soc 2001;44:31-32.
27. Ribeiro RT, Afonso RA, Macedo MP. Aged Wistar rats show a hepatic insulin sensitizing substance (HISS)-dependent insulin resistance. Proc West Pharmacol Soc 2002; (in press).
28. Ribeiro RT, Duarte-Ramos F, Macedo MP. The fatty Zucker rat fa/fa shows a dysfunction of the HISS-dependent and -independent components of insulin action. Proc West Pharmacol Soc 2001;44:29-30.
29. Moore MC, Satake S, Baranowski B, Hsieh P-S, Neal DW, Cherrington AD. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am J Physiol Endocrinol Metab 2002;282:E286-E296.
30. Lamarche L, Yamaguchi N, Peronnet F. Hepatic denervation reduces adrenal catecholamine secretion during insulin-induced hypoglycemia. Am J Physiol 1995;268:R50-R57.
31. Baron AD, Zhu JS, Marshall S, Irsula O, Brechtel G, Keech C. Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats. Am J Physiol Endocrinol Metab 1995;269:E709-E715.
32. Weigle DS. Pulsatile secretion of fuel-regulatory hormones. Diabetes 1987;36:764-775.
33. Boden G, Ruiz J, Urbain JL, Chen X. Evidence for a circadian rhythm of insulin secretion (abstract). Diabetes 1996;45:40A.
34. Lang DA, Matthews DR, Peto J, Turner RC. Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med 1979;301:1023-1027.
35. Even P, Danguir J, Nicolaidis S, Rougeot C, Dray F. Pulsatile secretion of growth hormone and insulin in relation to feeding in rats. Am J Physiol 1987;253:R772-R778.
36. Zarkovic M, Ciric J, Stojanovic M, Penezic Z, Trbojevic B, Drezgic M, Nesovic M. Effect of insulin sensitivity on pulsatile insulin secretion. Eur J Endocrinol 1999;141:494-501.
37. Simon C, Brandenberger G. Ultradian oscillations of insulin secretion in humans. Diabetes 2002;51(Suppl 1):S258-S261.
38. Voerman HJ, Strack, van Schijndel RJM, Groeneveld ABJ, de Boer H, Nauta JP, Thijs LG. Pulsatile hormone secretion during severe sepsis: Accuracy of different blood sampling regimens. Metabolism 1992;41:934-940.
39. Lang A, Matthews R, Burnett M, Turner RC. Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. Diabetes 1981;30:435-439.
40. Polonsky KS, Given BD, Hirsch LJ, Tillil H, Shapiro ET, Beebe C, Frank BH, Galloway JA, Van Cauter E. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 1988;18:1231-1239.
41. O'Meara NM, Sturis J, Cauter EV, Polonsky KS. Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J Clin Invest 1993;92:262-271.
42. Meneilly GS, Ryan AS, Veldhuis JD, Elahi D. Increased disorderliness of basal insulin release, attenuated insulin secretory burst mass, and reduced ultradian rhythmicity of insulin secretion in older individuals. J Clin Endocrinol Metab 1997;82:4088-4093.
43. O'Rahilly S, Turner RC, Matthews DR. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 1988;318:1225-1230.
44. Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 1978;202:631-633.
45. Petersen KF, Jacob R, West AB, Sherwin RS, Shulman GI. Effects on insulin-like growth factor I on glucose metabolism in rats with liver cirrhosis. Am J Physiol 1997;273:E1189-E1193.
46. Jacob R, Barrett E, Sherwin RS, Bowen L, Fryburg D, Fagin KD, Tamborlane WV, Shulman GI. Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats. Am J Physiol 1991;260:E262-E268.
47. Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001;414:821-827.